Latest Capital Markets News

Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.

DY6 Metals has clarified its compliance with ASX continuous disclosure rules following a material capital raising and CEO appointment, confirming timely and confidential handling of sensitive information.

Income Asset Management Group Limited delivered its strongest quarter ever in Q4 FY2025, reporting record revenue and robust growth in funds under advice alongside positive operating cash flow.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Macquarie Group Limited reported a 5% increase in FY25 profit to A$3.715 billion, declaring a higher dividend and announcing a key CFO transition. The group also outlined a strategic divestment and cautious outlook for FY26.

Agrimin Limited progresses its Mackay Potash Project with ongoing strategic review and strong stakeholder backing, while securing $2.5 million through equity placement and completing the Tali Resources IPO.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

IperionX has successfully commissioned its Virginia titanium manufacturing campus, secured a substantial U.S. Department of Defense contract, and raised $46 million to fast-track production expansion through 2030.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Cygnus Metals reports standout drilling results at its Chibougamau project, highlighting the new Golden Eye prospect and Corner Bay deposit, supported by a strong A$18.3 million capital raise to accelerate development.

Woodside Energy reported a 2% rise in quarterly production and lowered unit costs, while the Louisiana LNG Project’s final investment decision and a major Stonepeak partnership unlock significant future value.

InhaleRx Limited has secured key ethics approvals and initiated manufacturing for its inhaled drug candidates targeting breakthrough cancer pain and panic disorder, supported by a $38.5 million funding facility to accelerate development.